We are live on ! Find out more
TLOG

TetraLogic Pharmaceuticals Corporation
TLOG

Delisted

TLOG was delisted on the 3rd of November, 2016.

Back to rankings

33 hedge funds and large institutions have $14.7M invested in TetraLogic Pharmaceuticals Corporation in 2015 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 2

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

6% more funds holding

Funds holding: 31 → 33 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

48% less capital invested

Capital invested by funds: $28.3M → $14.7M (-$13.6M)

Holders
33
Holders Change
+2
Holders Change %
+6.45%
% of All Funds
0.89%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
9
Reduced
2
Closed
8
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
+$7K

Top Buyers

Rank Fund Capital Flow
1
First Eagle Investment Management
First Eagle Investment Management
New York
+$651K
2
FWC
First Washington Corp
Washington
+$402K
3
Lazard Asset Management
Lazard Asset Management
New York
+$279K
4
Millennium Management
Millennium Management
New York
+$182K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$163K

Top Sellers

Rank Fund Capital Flow
1
KCM
Kingdon Capital Management
New York
-$1.16M
2
EA
Emerald Advisers
Pennsylvania
-$662K
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$550K
4
IHM
Iguana Healthcare Management
New York
-$438K
5
PVI
Pura Vida Investments
New York
-$353K
Name Holding Trade Value Shares
Change 		Change in
Stake
CV
1
Clarus Ventures
Massachusetts
$10.9M – – –
First Eagle Investment Management
2
First Eagle Investment Management
New York
$762K +$651K +211,103 +184%
FWC
3
First Washington Corp
Washington
$747K +$402K +130,400 +69%
Vanguard Group
4
Vanguard Group
Pennsylvania
$433K +$163K +52,785 +40%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$308K – – –
Lazard Asset Management
6
Lazard Asset Management
New York
$211K +$279K +90,436 New
Alyeska Investment Group
7
Alyeska Investment Group
Illinois
$196K +$4.19K +1,357 +2%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$178K +$103K +33,487 +78%
CCA
9
Catalyst Capital Advisors
New York
$164K – – –
Morgan Stanley
10
Morgan Stanley
New York
$156K +$43.9K +14,231 +27%
HighTower Advisors
11
HighTower Advisors
Illinois
$144K – – –
Millennium Management
12
Millennium Management
New York
$138K +$182K +58,897 New
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$84K – – –
Goldman Sachs
14
Goldman Sachs
New York
$59K -$18.4K -5,961 -19%
VKH
15
Virtu KCG Holdings
New York
$52K +$7.77K +2,518 +13%
Jacobs Levy Equity Management
16
Jacobs Levy Equity Management
New Jersey
$36K +$46.9K +15,200 New
Bank of New York Mellon
17
Bank of New York Mellon
New York
$32K +$4.78K +1,550 +13%
MWP
18
MYCIO Wealth Partners
Pennsylvania
$28K – – –
CC
19
Cannell & Co
New York
$27K +$36.1K +11,713 New
SIM
20
Spark Investment Management
New York
$25K +$34.2K +11,100 New
BCM
21
Bridgeway Capital Management
Texas
$24K – – –
BJ
22
BlackRock Japan
Japan
$15K +$19.4K +6,287 New
GT
23
Glenmede Trust
Pennsylvania
$9K – – –
UBS Group
24
UBS Group
Switzerland
$8K -$14.2K -4,588 -58%
Group One Trading
25
Group One Trading
Illinois
$7K +$9.25K +3,000 New
1
2

TLOG Hedge Fund Activity: Q2 2015 in Review

33 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in TetraLogic Pharmaceuticals Corporation (TLOG) for Q2 2015, worth a combined $14.7M — down 48% from $28.3M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new TLOG positions and 8 closed out — a net gain of 2 holders — while 9 added to existing stakes and 2 trimmed.

The largest buyer was First Eagle Investment Management, adding an estimated $651K. The largest seller was Kingdon Capital Management, exiting entirely with an estimated $1.16M sold.

  • 33 institutional investors held TetraLogic Pharmaceuticals Corporation (TLOG) as of Q2 2015, up from 31 in Q1 2015.
  • Funds reported $14.7M of TetraLogic Pharmaceuticals Corporation stock for Q2 2015, down 48% quarter-over-quarter.
  • 10 funds opened new TetraLogic Pharmaceuticals Corporation positions in Q2 2015 and 8 closed out, a net change of +2 holders.
  • The largest TetraLogic Pharmaceuticals Corporation buyer in Q2 2015 was First Eagle Investment Management, an estimated $651K added.
  • The largest TetraLogic Pharmaceuticals Corporation seller in Q2 2015 was Kingdon Capital Management, an estimated $1.16M sold.

Based on aggregated 13F filings for Q2 2015.